Published 2019
| Version v1
Publication
Response to letter to the editor: switch to dolutegravir and unboosted atazanavir
Contributors
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/988489
- URN
- urn:oai:iris.unige.it:11567/988489
Origin repository
- Origin repository
- UNIGE